Impact of Reduced Vancomycin MIC on Clinical Outcomes of Methicillin-Resistant Staphylococcus aureus Bacteremia

Vancomycin has been a key antibiotic agent for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections. However, little is known about the relationship between vancomycin MIC values at the higher end of the susceptibility range and clinical outcomes. The aim of this study was...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Park, So-Youn, Oh, In-Hwan, Lee, Hee-Joo, Ihm, Chun-Gyoo, Son, Jun Seong, Lee, Mi Suk, Kim, Mi-Na
Natura: Artigo
Lingua:Inglês
Pubblicazione: American Society for Microbiology 2013
Soggetti:
Susceptibility
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3811271/
https://ncbi.nlm.nih.gov/pubmed/23979741
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01137-13
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi